About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.03 (-4.63%)
CMMB NASDAQ Chemomab Therapeutics Ltd DRC
Chemomab Therapeutics Ltd DRC share price
CMMB price activity
Last Price
$1.030
Change (24hr)
-0.05 USD (4.63%)
Volume
25.09K
Volume (4w avg)
-
Open
$1.10
Day Range
$1.01 - $1.21
Previous Close
$1.08
Last Trade
23 Oct, 8:00 pm GMT+0
Delayed
23 Oct, 8:00 pm GMT+0
CMMB price performance
Delayed
23 Oct, 8:00 pm GMT+0
CMMB Market Signals